Description: MONTREAL — Just when it seemed Valeant Pharmaceuticals Inc. was in the clear after being called out by U.S. politicians during a recent drug-pricing controversy, the Laval, Que.-based company is once again in the hot seat as it faces subpoenas from two federal prosecutors.
Date: Oct 16, 2015
Questions for Discussions:
- What is the ethical issue here?
- How would you expect this story to end?
- Do you think the firm would be facing similar controversy if the products were not drugs?